<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Paul Schuette | R/Pharma</title>
    <link>/author/paul-schuette/</link>
      <atom:link href="/author/paul-schuette/index.xml" rel="self" type="application/rss+xml" />
    <description>Paul Schuette</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© R/Pharma 2025</copyright><lastBuildDate>Fri, 01 Jan 1999 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/media/logo_hu7da996d8ce7178f65929875a2132de7e_457633_300x300_fit_lanczos_2.png</url>
      <title>Paul Schuette</title>
      <link>/author/paul-schuette/</link>
    </image>
    
    <item>
      <title>Simulations, and Complex Innovative Trial Designs</title>
      <link>/publication/rinpharma_128/</link>
      <pubDate>Fri, 01 Jan 1999 00:00:00 +0000</pubDate>
      <guid>/publication/rinpharma_128/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Submitting Data to CDER: What Comes Next?</title>
      <link>/publication/rinpharma_224/</link>
      <pubDate>Fri, 01 Jan 1999 00:00:00 +0000</pubDate>
      <guid>/publication/rinpharma_224/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Using R in a regulatory environment: some FDA perspectives</title>
      <link>/publication/rinpharma_136/</link>
      <pubDate>Fri, 01 Jan 1999 00:00:00 +0000</pubDate>
      <guid>/publication/rinpharma_136/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
